Vir Biotechnology
157 hedge funds and large institutions have $3.87B invested in Vir Biotechnology in 2021 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 38 increasing their positions, 66 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
2.77% less ownership
Funds ownership: 61.95% → 59.19% (-2.8%)
18% less call options, than puts
Call options by funds: $34.5M | Put options by funds: $42.2M
42% less repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 66
Holders
157
Holding in Top 10
7
Calls
$34.5M
Puts
$42.2M
Top Buyers
| 1 | +$28.1M | |
| 2 | +$24.3M | |
| 3 | +$24.1M | |
| 4 |
MM
MWG Management
Road Town, Tortola,
British Virgin Islands
|
+$17.5M |
| 5 |
Morgan Stanley
New York
|
+$16.6M |
Top Sellers
| 1 | -$62.9M | |
| 2 | -$59.5M | |
| 3 | -$57M | |
| 4 |
APF
Alaska Permanent Fund
Juneau,
Alaska
|
-$53.9M |
| 5 |
BlackRock
New York
|
-$8.79M |